Gene expression and pain

Details for Australian Patent Application No. 2008251320 (hide)

Owner Adynxx, Inc.

Inventors Mamet, Julien

Agent Davies Collison Cave

Pub. Number AU-A-2008251320

PCT Pub. Number WO2008/141308

Priority 60/917,583 11.05.07 US

Filing date 12 May 2008

Wipo publication date 20 November 2008

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2008/141308 Priority application(s): WO2008/141308

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008251324-((Phenyl)imidazolyl)methylheteroaryl compounds

2008251316-Combined wavefront and topography systems and methods